By Drug Target Review2024-07-15T12:00:44
Researchers have developed a prediction model to ascertain breast cancer survivors’ risk of persistent taxane-induced peripheral neuropathy.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-03-26T13:58:00Z
2026-03-18T14:47:08Z
2024-01-10T08:23:16
Sponsored by BellBrook Labs
2023-09-27T13:56:39
Sponsored by Euretos
2023-02-07T15:25:20
Sponsored by Bio-Techne
2024-01-26T13:22:42
Sponsored by bit.bio
2023-07-04T10:05:58
Sponsored by Revvity
2024-05-10T11:23:31
Sponsored by BellBrook Labs
Site powered by Webvision Cloud